Per 1 ml of the product:
active ingredients:
phenobarbital – 18.40 mg
ethylbromisovalerianate – 18.40 mg
excipients: mint oil, hop oil, 96% ethanol, potassium hydroxide, purified water.

- functional disorders of the cardiovascular system (including cardialgia and sinus tachycardia)
- neuroses with irritability, anxiety, and fear
- insomnia (difficulty falling asleep)
- excitatory states with pronounced vegetative reactions.

Valocordin® should be administered orally with meals, with a small amount of water. The dosage and duration of treatment should be determined on an individual basis.
Adults are usually prescribed 22-30 drops 3 times a day.
If sleep is disturbed, the dose may be increased to 45 drops.

When administered concurrently with sedatives, Valocordin® may enhance their sedative effect. Сoncomitant administration of Valocordin® and neuroleptic agents and antianxiety agents enhances the effects of each of the drug ingredients; concurrent use of the product and central nervous system stimulants suppresses the effects of each of the drug ingredients. Alcohol enhances the effects of Valocordin® and may increase its toxicity. Phenobarbital contained in Valocordin® may induce liver enzymes, and this makes its concurrent use with drugs that are metabolized in the liver undesirable, as their concentration and consequent efficacy decrease as a result of accelerated metabolism (indirect anticoagulants, antibiotics, sulfonamides, etc.).
Pharmaceutical products containing valproinic acid enhance the effect of barbiturates.
Valocordin® contains phenobarbital, therefore, concomitant administration of this product and coumarin derivatives, griseofulvin, glucocorticoids, or oral contraceptives may lead to adverse interaction in the form of accelerated reduction of the effects of the above drugs.
It enhances the toxicity of pharmaceutical products containing methotrexate.

Long-term use of the drug may lead to drug dependence; bromine may accumulate in the body and cause intoxication.

Do not store above 25°C.
Keep out of reach of children.

5 years.

Krewel Meuselbach GmbH, Germany
Legal Address
2 Krewelstrasse, 53783 Eitorf, Germany
Site of Manufacture
Xavier-Vorbruggen-Strasse 6, 98694, Ilmenau, Germany